Mumbai, June 25 -- Lupinhas received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Prucalopride Tablets, 1 mg, and 2 mg.

Published by HT Digital Content Services with permission from Capital Market....